Nardini, M., et al. «Treatment of Depression with L-5-Hydroxytryptophan Combined with Chlorimipramine, A Double-Blind Study», International Journal of Clinical Pharmacology Research 3, no. 4 (1983): 239–50.
Ribeiro, C. A., «L-5-hydroxytryptophan in the Prophylaxis of Chronic Tension-type Headache: A Double-Blind, Randomized, Placebo-Controlled Study. For the Portuguese Head Society», Headache 40, no. 6 (2000): 451–56.
Rousseau, J. J., «Effects of a Levo-5-Hydroxytryptophan-Dihydroergocristine Combination on Depression and Neuropsychic Performance: A Double-Blind Placebo-Controlled Clinical Trial in Elderly Patients», Clinical Therapeutics 9, no. 3(1987): 267–72.
Barak, Y., et al. «Inositol Treatment of Alzheimer’s Disease: A Double-Blind, Cross-over Placebo-Controlled Trial», Progress in Neuropsychopharmacological and Biological Psychiatry 20 (1996): 729–35.
Benjamin, J., et al. «Double-Blind, Placebo-Controlled, Crossover Trial of Inositol Treatment for Panic Disorder», American Journal of Psychiatry 152 (1995): 1084–86.
Einat, H., et al. «Inositol Reduces Depressive-like Behaviors in Two Different Models of Depression», Psychopharmacology 144 (1999): 158–62.
Fox, М., et al. «Inositol Treatment of Obsessive-Compulsive Disorder», American Journal of Psychiatry 153 (1996): 1219–21.
Levine, J., «Controlled Trials of Inositol in Psychiatry», European Neuropsychopharmacology 7 (1997): 147–55.
Levine, J., et al. «Double-Blind, Controlled-Trial of Inositol Treatment of Depression», American Journal of Psychiatry 152 (1995): 792–94.
Levine, J., et al. «CSF Inositol in Schizophrenia and High-Dose Inositol Treatment of Schizophrenic», European Neuropsychopharmacology 4 (1994): 487–90.
Seedat, S., and D.J. Stein, «Inositol Augmentation of Serotonin Reuptake Inhibitors in Treatment-Refractory Obsessive-Compulsive Disorder: An Open Trial», International Clinical Psychopharmacology 14 (1999): 353–56.
Davidson, J. R. Т., and К. M. Connor, «Valerian», in Herbs for the Mind: Depression, Stress, Memory Loss, and Insomnia (New York: Guilford Press, 2000), 214–33.
Donath, F., et al., «Roots I: Critical Evaluation of the Effect of Valerian Extract on Sleep Structure and Sleep Quality», Pharmacopsychiatry 33 (2000): 47–53.
Dorn, M., «Valerian Versus Oxazepam: Efficacy and Tolerability in Nonorganic and Nonpsychiatric Insomniacs: A Randomized, Double-Blind, Clinical Comparative Study [in German]», Forschende Komplementarmedizin und Klassische Naturheilkunde 7 (2000): 79–84.
Russo, E. В., «Valerian», in Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies in Psychiatric Conditions (Binghamton, N.Y.: Haworth Press, (2001), 95–706.
Vorbach, E. U., R. Gortelmeyer, and J. Bruning, «Treatment of Insomnia: Effectiveness and Tolerance of a Valerian Extract», Psychopharmakotherapie 3 (1996): 109–15.
Amen, D. G., «Attention Deficit Disorder: A Guide for Primary Care Physicians», Primary Psychiatry 5, no. 7 (July 1998): 76–85.
«Change Your Brain, Change Your Life» (New York: Three Rivers Press, 1999).
«Images of Human Behavior», A Brain SPECT Atlas (Newport Beach, Calif.: Mindworks Press, 2001).
«Healing ADD: The Breakthrough Program That Allows You to See and Heal the Six Types of Attention Deficit Disorder» (New York: G.P. Putnam and Sons, 2001).
Amen, D. G., with L. Routh, «Healing Anxiety and Depression» (New York: Putnam, 2003).
Amen, D. G., «Why Don’t Psychiatrists Look at the Brain: The Case for the Greater Use of SPECT Imaging in Neuropsychiatry», Neuropsychiatry Reviews 2, no. 1 (February 2001): 19–21.